secwatch.observer — SEC 8-K summary
======================================

Issuer:     Centessa Pharmaceuticals plc (CNTA)
CIK:        0001847903
Form:       8-K
Filed at:   2022-07-08T23:59:59+00:00
Accession:  0001847903-22-000042
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Centessa CAO resigns; CFO to add principal accounting officer role; RSU retention grants approved
--------------------------------------------------------------------------------

- Marella Thorell resigns as Chief Accounting Officer effective July 31, 2022, to pursue another opportunity; no disagreement with the company.
- CFO Gregory Weinhoff will assume principal accounting officer duties effective July 31, in addition to his CFO role.
- Board approved RSU retention grants: CEO Saurabh Saha 750,000 shares, CFO Weinhoff 230,000, EVP Yver 100,000; vest quarterly over 10 quarters starting Sept 30, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847903/000184790322000042/0001847903-22-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847903/000184790322000042/cnta-20220701.htm
  HTML page:      https://secwatch.observer/filing/0001847903-22-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer